FDA Approved: SIVEXTRO — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA's original approval of Sivextro (tedizolid phosphate) by Merck Sharp & Dohme LLC for acute bacterial skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Sivextro (tedizolid)

Snippet

ORIG AP for SIVEXTRO (TEDIZOLID PHOSPHATE)